Abstract
NHS Tayside, UK, identified risks with subcutaneous insulin therapy for hospital in-patients: overlooked abnormal blood glucose readings; prescription errors and failure to administer insulin. Involvement in the Safer Patients Initiative provided opportunities to use different methods of quality improvement, to create a process that facilitated prevention, detection and mitigation of diabetes management problems for in-patients requiring subcutaneous insulin therapy. The aim was to explain these methods, their use and results obtained.
| Original language | English |
|---|---|
| Pages (from-to) | 960-967 |
| Number of pages | 8 |
| Journal | Diabetic Medicine |
| Volume | 25 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- Diabetes Mellitus
- Hospitalization
- Hospitals
- Humans
- Hypoglycemic Agents
- Injections, Subcutaneous
- Insulin
- Medical Records
- Quality of Health Care
- Risk Assessment
Fingerprint
Dive into the research topics of 'MEASURE IT, IMPROVE IT: the Safer Patients Initiative and quality improvement in subcutaneous insulin therapy for hospital in-patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver